Clinical Trial Update: Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

View source ↗

Summary

This completed clinical trial evaluates the feasibility of a smartphone app for patients with advanced renal cell carcinoma undergoing combination immunotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Renal Cell Carcinoma Stage IV | Status: COMPLETED